Key Takeaways
- • Oxylabs, a data infrastructure platform, secured $130 million in Series D funding from Warburg Pincus, valuing the company at $3.6 billion as of July 9, 2026.
- • Five law firms guided the transaction, underscoring the complexity and scale of the deal structure for institutional investors in the data infrastructure sector.
- • The investment reflects continued institutional capital flow into data infrastructure and web intelligence platforms, with Warburg Pincus positioning itself as a lead investor in this vertical.
- • Oxylabs' $3.6 billion post-money valuation signals market confidence in data collection and management solutions serving enterprise clients.
Summary
Oxylabs announced a $130 million Series D funding round led by private equity firm Warburg Pincus on July 9, 2026, establishing a $3.6 billion valuation for the data infrastructure platform. The transaction represents a significant capital infusion into the enterprise data services sector and demonstrates sustained investor appetite for companies operating in the data intelligence and web scraping landscape.
The deal structure involved five law firms coordinating legal guidance, reflecting the multifaceted regulatory, contractual, and operational considerations inherent in large-scale venture and growth equity transactions in the data infrastructure space. This multi-counsel approach typically indicates navigating complex licensing arrangements, data privacy compliance across jurisdictions, and institutional investor requirements common to Series D fundraising at this valuation tier.
Warburg Pincus' participation as lead investor underscores the private equity firm's strategic focus on infrastructure and software-as-a-service platforms with recurring revenue models. For institutional investors monitoring the data infrastructure sector, this investment validates the commercial viability and market demand for Oxylabs' platform, which serves enterprise clients requiring large-scale data collection and processing capabilities.
The $3.6 billion valuation places Oxylabs among the higher-valued private companies in its sector, suggesting the company has demonstrated strong revenue traction, customer retention, and market positioning prior to this funding round. This valuation and investment size are consistent with growth-stage capital allocation patterns targeting mature software platforms with established customer bases and clear paths to profitability or exit.
The deal structure involved five law firms coordinating legal guidance, reflecting the multifaceted regulatory, contractual, and operational considerations inherent in large-scale venture and growth equity transactions in the data infrastructure space. This multi-counsel approach typically indicates navigating complex licensing arrangements, data privacy compliance across jurisdictions, and institutional investor requirements common to Series D fundraising at this valuation tier.
Warburg Pincus' participation as lead investor underscores the private equity firm's strategic focus on infrastructure and software-as-a-service platforms with recurring revenue models. For institutional investors monitoring the data infrastructure sector, this investment validates the commercial viability and market demand for Oxylabs' platform, which serves enterprise clients requiring large-scale data collection and processing capabilities.
The $3.6 billion valuation places Oxylabs among the higher-valued private companies in its sector, suggesting the company has demonstrated strong revenue traction, customer retention, and market positioning prior to this funding round. This valuation and investment size are consistent with growth-stage capital allocation patterns targeting mature software platforms with established customer bases and clear paths to profitability or exit.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.